Short-Term Treatment with Low-Dose Pravastatin Attenuates Oxidative Susceptibility of Low-Density Lipoprotein in Hypercholesterolemic Patients

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cardiovascular Drugs and Therapy

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1007722426016PMID 9512874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

  2004cited by this paper
• Effect of temperature and phase transition on oxidation resistance of low density lipoprotein.

  1995cited by this paper
• Effects of acute exercise on the changes of lipid profiles and peroxides, prostanoids, and platelet activation in hypercholesterolemic patients before and after treatment.

  1994cited by this paper
• Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance

  1994cited by this paper
• Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys.

  1994influential reference
• Decreased in vitro oxidizability of low‐density lipoprotein in hypercholesterolaemic patients treated with 3‐hydroxy‐3‐methyIgIutaryl‐CoA reductase inhibitors

  1993cited by this paper
• Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.

  1993cited by this paper
• Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia.

  1993cited by this paper
• Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.

  1993cited by this paper
• Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

  1993cited by this paper
• The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

  1992cited by this paper
• Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.

  1992cited by this paper
• Protection by glutathione and other thiol compounds against the loss of protein thiols and tocopherol homologs during microsomal lipid peroxidation.

  1992cited by this paper
• Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size.

  1992cited by this paper
• Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozil

  1991cited by this paper
• Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

  1991cited by this paper
• The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia

  1990cited by this paper
• Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

  1990cited by this paper
• Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity.

  1990cited by this paper
• Malondialdehyde affects the physico-chemical and biological characteristics of oxidized low density lipoprotein.

  1990cited by this paper
• Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins

  1990cited by this paper
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

  1989cited by this paper
• Continuous monitoring of in vitro oxidation of human low density lipoprotein.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

  1987cited by this paper
• Free radical modification of low-density lipoprotein: mechanisms and biological consequences.

  1987cited by this paper
• The role of altered lipoproteins in the pathogenesis of atherosclerosis.

  1987cited by this paper
• A simple immunotechnique for the determination of serum concentration of apolipoprotein E.

  1987cited by this paper
• Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.

  1986cited by this paper
• Assay for blood plasma or serum.

  1984cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• A peroxidase-coupled method for the colorimetric determination of serum triglycerides.

  1983cited by this paper
• Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholeserolemia heterozygotes. 1983.

  1983cited by this paper
• Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

  1979cited by this paper
• A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood.

  1979influential reference
• Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. III. Intracellular localization of cholesterol and cholesteryl ester.

  1979cited by this paper
• Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations.

  1979cited by this paper
• Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

  1979cited by this paper
• A new enzymatic method for determination of serum choline-containing phospholipids.

  1977cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Critical analysis of radical scavenging properties of atorvastatin in methanol recently estimated via density functional theory

  2022cites this paper
• Theoretical Insight into mechanism of antioxidant capacity of atorvastatin and its o-hydroxy and p-hydroxy metabolites, using DFT methods

  2022cites this paper
• A Systematic Review and Meta-Analysis of the Effect of Statins on Glutathione Peroxidase, Superoxide Dismutase, and Catalase

  2021influential citation
• Pravastatin improves risk factors but not ischaemic tolerance in obese rats

  2018cites this paper
• Preventive effect of pravastatin on the development of hypertension in patients with hypercholesterolemia: A post-hoc analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.

  2017cites this paper
• Ameliorative effect of statin therapy on oxidative damage in heart tissue of hypercholesterolemic rabbits

  2015cites this paper
• Do statins have a role in reduction/prevention of post-PCI restenosis?

  2013cites this paper
• The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.

  2012cites this paper
• [Similarities, differences and agonisms of pleiotropic effects of statins and omega-3 fatty acids].

  2010cites this paper
• Similitudes, diferencias y agonismos en los efectos pleiotrópicos de las estatinas y los ácidos grasos omega-3

  2010cites this paper
• Exercise training improves cardiac function in infarcted rabbits: involvement of autophagic function and fatty acid utilization

  2010influential citation
• A proteomic study of the effects of ramipril on post‐infarction left ventricular remodelling in the rabbit

  2008cites this paper
• Statin therapy in cardiovascular diseases other than atherosclerosis

  2007cites this paper
• Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients.

  2005cites this paper
• Statins and Modulation of Oxidative Stress

  2005influential citation
• Effect of Pravastatin on Low-Density Lipoprotein Oxidation and Myocardial Perfusion in Young Adults With Type 1 Diabetes

  2004cites this paper
• Effects of fluvastatin in type 2 diabetic patients with hyperlipidemia: reduction in cholesterol oxidation products and VCAM-1.

  2004cites this paper
• A comparative study of the in vitro antioxidant activity of statins.

  2003cites this paper
• Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients.

  2001cites this paper
• Nilvadipine protects low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis

  2000cites this paper
• Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters.

  2000cites this paper
• Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis.

  1999cites this paper